Consistent with the induction of the p53 downstream targets, BTG2, TP53INP1 and SESN1, all of which have tumour-suppressor functions on their own2, 23, 24, SETD1A depletion suppresses tumour growth in vivo. The gene discussed is BTG2; the disease is neoplasm.